Garland Capital Management Inc Novartis Ag Transaction History

Garland Capital Management Inc

  • $130 Million
  • Q3 2024

A detailed history of Garland Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Garland Capital Management Inc holds 42,195 shares of NVS stock, worth $4.1 Million. This represents 3.73% of its overall portfolio holdings.

Number of Shares
42,195
Previous 50,010 15.63%
Holding current value
$4.1 Million
Previous $5.32 Million 8.85%
% of portfolio
3.73%
Previous 3.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$106.13 - $120.89 $4.48 Million - $5.1 Million
42,195 New
42,195 $4.85 Million
Q2 2024

Jul 30, 2024
SELL
$92.57 - $107.37 $68,038 - $78,916
-735 Reduced 1.45%
50,010 $5.32 Million
Q1 2024

Apr 30, 2024
BUY
$95.27 - $108.47 $4.83 Million - $5.5 Million
50,745 New
50,745 $4.91 Million
Q4 2023

Jan 29, 2024
SELL
$92.27 - $101.54 $313,718 - $345,236
-3,400 Reduced 6.21%
51,310 $5.18 Million
Q3 2023

Oct 31, 2023
SELL
$94.73 - $105.13 $7,104 - $7,884
-75 Reduced 0.14%
54,710 $5.57 Million
Q2 2023

Jul 20, 2023
BUY
$92.52 - $104.91 $5.07 Million - $5.75 Million
54,785 New
54,785 $5.53 Million
Q1 2023

Apr 25, 2023
BUY
$80.03 - $92.81 $4.31 Million - $5 Million
53,885 New
53,885 $4.96 Million
Q4 2022

Jan 19, 2023
BUY
$75.55 - $92.52 $168,854 - $206,782
2,235 Added 4.09%
56,920 $0
Q3 2022

Oct 20, 2022
BUY
$74.61 - $87.26 $4.08 Million - $4.77 Million
54,685 New
54,685 $4.16 Million
Q2 2022

Jul 20, 2022
BUY
$80.52 - $93.75 $3.95 Million - $4.6 Million
49,095 New
49,095 $4.15 Million
Q1 2022

Apr 27, 2022
BUY
$80.11 - $90.62 $14,019 - $15,858
175 Added 0.37%
47,630 $4.18 Million
Q4 2021

Feb 03, 2022
SELL
$79.7 - $88.13 $263,010 - $290,829
-3,300 Reduced 6.5%
47,455 $4.15 Million
Q3 2021

Oct 27, 2021
SELL
$81.78 - $95.14 $8,178 - $9,514
-100 Reduced 0.2%
50,755 $4.15 Million
Q2 2021

Jul 27, 2021
SELL
$85.24 - $94.15 $4.33 Million - $4.79 Million
-50,855 Closed
0 $0
Q1 2021

Apr 21, 2021
BUY
$83.5 - $98.47 $4.25 Million - $5.01 Million
50,855 New
50,855 $4.35 Million
Q4 2020

Feb 09, 2021
SELL
$78.07 - $94.43 $15,613 - $18,886
-200 Reduced 0.39%
50,705 $4.79 Million
Q3 2020

Apr 21, 2021
SELL
$82.14 - $91.0 $5.57 Million - $6.17 Million
-67,805 Reduced 57.12%
50,905 $4.43 Million
Q3 2020

Oct 22, 2020
BUY
$82.14 - $91.0 $5.56 Million - $6.16 Million
67,705 Added 132.74%
118,710 $10.3 Million
Q2 2020

Jul 24, 2020
SELL
$80.93 - $91.1 $206,371 - $232,305
-2,550 Reduced 4.76%
51,005 $4.46 Million
Q1 2020

Apr 13, 2020
SELL
$70.67 - $99.01 $53,002 - $74,257
-750 Reduced 1.38%
53,555 $4.42 Million
Q4 2019

Jan 24, 2020
SELL
$84.35 - $95.37 $8,435 - $9,537
-100 Reduced 0.18%
54,305 $5.14 Million
Q3 2019

Oct 10, 2019
SELL
$85.54 - $94.26 $45,763 - $50,429
-535 Reduced 0.97%
54,405 $4.73 Million
Q2 2019

Jul 24, 2019
BUY
$75.4 - $92.8 $35,815 - $44,080
475 Added 0.87%
54,940 $5.02 Million
Q3 2018

Mar 12, 2019
SELL
$66.94 - $77.43 $26,776 - $30,972
-400 Reduced 0.73%
54,465 $4.69 Million
Q3 2018

Oct 22, 2018
SELL
$66.94 - $77.43 $3.67 Million - $4.25 Million
-54,865 Closed
0 $0
Q2 2018

Jul 13, 2018
BUY
$64.91 - $73.36 $86,460 - $97,715
1,332 Added 2.49%
54,865 $4.14 Million
Q1 2018

Apr 24, 2018
BUY
$70.39 - $84.15 $91,507 - $109,395
1,300 Added 2.49%
53,533 $4.33 Million
Q4 2017

Jan 25, 2018
BUY
$72.33 - $77.64 $38,696 - $41,537
535 Added 1.03%
52,233 $4.39 Million
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $3.83 Million - $3.99 Million
51,698
51,698 $4.44 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Garland Capital Management Inc Portfolio

Follow Garland Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garland Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email